ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 121 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $56,949,000 | -39.1% | 2,026,656 | 0.0% | 0.26% | -31.2% |
| Q1 2022 | $93,510,000 | -47.5% | 2,026,656 | -4.3% | 0.38% | -26.3% |
| Q4 2021 | $178,063,000 | +26.1% | 2,118,284 | 0.0% | 0.51% | +32.6% |
| Q3 2021 | $141,162,000 | +10.6% | 2,118,284 | -11.7% | 0.39% | 0.0% |
| Q2 2021 | $127,642,000 | +22.6% | 2,399,284 | 0.0% | 0.39% | +24.8% |
| Q1 2021 | $104,105,000 | -33.4% | 2,399,284 | -20.3% | 0.31% | -27.9% |
| Q4 2020 | $156,406,000 | +7.7% | 3,011,284 | -32.2% | 0.43% | -18.1% |
| Q3 2020 | $145,251,000 | -31.9% | 4,443,284 | 0.0% | 0.52% | -43.1% |
| Q2 2020 | $213,366,000 | – | 4,443,284 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 2,099,583 | $42,117,635 | 14.06% |
| Mayo Clinic | 187,143 | $3,754,089 | 7.23% |
| Matrix Capital Management Company, LP | 13,959,973 | $280,037,058 | 3.36% |
| 5AM Venture Management, LLC | 490,000 | $9,829,400 | 2.83% |
| Eventide Asset Management | 7,814,039 | $156,749,622 | 2.82% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 961,486 | $19,287,410 | 2.70% |
| Avidity Partners Management LP | 2,100,000 | $42,126,000 | 1.70% |
| First Light Asset Management, LLC | 848,477 | $17,020,449 | 1.62% |
| Sofinnova Investments, Inc. | 1,211,641 | $24,305,518 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 386,525 | $7,753,692 | 1.51% |